论文部分内容阅读
对早产孕妇临产前用药,促进胎儿肺成熟,已是临床预防早产儿肺透明膜病的重要方法.目前使用较多而且效果肯定的药物为肾上腺皮质激素.我们观察了19例安普索(Ambroxol)(由台湾全福化学股份有限公司生产),预防早产儿肺透明膜病,并同30例地塞米松组对照,报道如下.1 资料与方法1.1病例选择 1995年5月～1996年4月对妊娠29～37周,年龄23～33岁,有明显引起早产或因病情需要必须提早终止妊娠的孕妇,在出生前1周内给孕妇使用促胎肺成熟药物2～3天.观察组19例,平均26.68±
Prenatal medication for preterm prenatal care to promote fetal lung maturity is already an important method of clinical prevention of hyaline membrane disease in premature infants.At present, the more used and effective drugs for the adrenal hormones.We observed 19 cases of Ambroxol ) (From Taiwan Quan Fu Chemical Co., Ltd.), prevention of hyaline membrane disease in preterm children, and 30 cases of dexamethasone group control, reported as follows.1 Materials and Methods 1.1 Case Selection May 1995 ~ April 1996 Pregnancy 29 to 37 weeks, aged 23 to 33 years old, obviously premature or premature termination of pregnancy due to illness need to pregnant women within 1 week before birth to promote the use of fetal growth-promoting drugs mature 2 to 3 days observation group 19 For example, an average of 26.68 ±